Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Supplementation in Diabetic Nephropathy
NCT03824379Phase 2Completed
- Sponsor
- Ain Shams University
- Start
- Jun 2019
- Primary completion
- Mar 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised trial of magnesium in diabetic nephropathy (DN) (2 arms), sponsored by Ain Shams University. Primary endpoint: Human Serum Osteocalcin level at 12 weeks. Started Jun 2019; status: completed.
02
Drugs
magnesium
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT03824379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03824379.